Oncology
- Ref-No.Technology
- 01-00986
Non-invasive and high-throughput monitoring of exon-specific isoform expression
- 01-00988
INSPECT - Intron encoded reporter transcripts for minimally invasive monitoring of coding and non-coding RNAs
- 01-01042
IDC-like 3D mammary organoids derived from healthy primary luminal cells with invasive potential
- 01-01045
Ex vivo method for determination of oxidative stress and diagnosis of ferroptosis-associated diseases
- 01-01080
Drug combinations to overcome therapy resistance in cancer
- 02-00350Novel Ratjadones as payloads in folate-, peptide-, and antibody-drug conjugates for the treatment of cancer
- 03-00352
Repurposing Niclosamide for (neo-)adjuvant cancer therapy
- 03-00397
Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
- 03-00413
Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
- 03-00417
Novel BCMA-CAR for the treatment of multiple myeloma and non-Hodgkin lymphoma (NHL)
- 03-00430
Selective Inhibitors of Genotoxic Stress Induced IKK/NFκB Pathways for Cancer Therapy
- 03-00475
Novel combination of inhibitors of WNT and MACC1 for cancer therapy
- 03-00539Sleeping Beauty transposase variants with increased safety due to reduced half-life
- 03-00553
Human TCR constructs for adoptive cell therapy of cancer
- 10-00107Barnesins – novel natural small molecules as highly specific cysteine protease inhibitors
- 11-00057Innovative Nerve Sheath Tumor Therapy
- 14-00013MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
- 14-00135
Epigenetic detection of early-stage non-small cell lung cancer in blood
- 14-00176
Efficient, adjuvant-free mucosal vaccination via IgA feedback loop
- 15-00371
lncRNAs in therapy and diagnosis of disease related angiogenesis
- 15-00502
Predicting the therapeutic effect of compositions containing BH3 mimetics
- 15-00514
LS-COAT – an exceptionally efficient tumor vaccination approach
- 15-00604
Novel Diagnostic Marker For Early Detection Of Bladder Cancer
- 15-00612TCR-agnostic identification of tumor-specific T cells for cancer diagnostics and therapy
- 15-00751
Prediction of L-Asparaginase resistance in tumor therapy
- 22-00017Functional IFN-gamma memory in CD4+ T cells: Method for improved T cell therapy and disease monitoring in autoimmune diseases
- 32-00059
T-cell therapy of MYD88L265P-dependent B-cell lymphoma
- 32-00076
Next generation allogeneic CAR-NK cell platform for treatment of malignant diseases
- 32-00124
TCR/CD3-specific CAR NK-92 cells for purification of TCR-modified T cell products
- 32-00164
The CXCR3alt-CXCL11 chemokine system for therapeutic use in solid cancer
- 42-00040
Otviciclib - a new pan-CDK inhibitor in oncology
- 43-00006Genetically engineered human 3D brain tumor models for disease modeling and compound evaluation
- 43-00013
CRISPR StAR: sgRNA expression vectors for reliable and reproducible in vivo screenings
- 43-00016
SARSeq: Multiplexed, parallel detection of SARS-CoV2 variants and other viruses in high-throughput
- 49-00012
A novel approach for acute leukocyte mobilization from the bone marrow
- 99-00160
E-Morph Assay – an innovative image-based phenotypic screening assay for estrogenic and anti-estrogenic activity
